Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Middle East News Digest.
Press releases published on April 2, 2025

Nayax gibt Übernahme von Inepro Pay bekannt
HERZLIYA, Israel, April 02, 2025 (GLOBE NEWSWIRE) -- Nayax Ltd. (Nasdaq: NYAX; TASE: NYAX), eine globale Plattform für Handelsförderung und Zahlungen, die Händlern dabei helfen soll, ihr Geschäft durch die Vereinfachung von Zahlungen und die Maximierung …

AssistRx Completes Asset Acquisition from AllazoHealth, Strengthening its Advanced Tech + Talent Patient Support Services
ORLANDO, Fla., April 02, 2025 (GLOBE NEWSWIRE) -- AssistRx, the advanced therapy initiation and patient solutions provider, today announced it has completed an asset acquisition from AllazoHealth, a healthcare technology company driving therapy initiation, …

Polyrizon Engages Leading Branding Firm for Strategic Brand Development
Raanana, Israel, April 02, 2025 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (Nasdaq: PLRZ), a biotech company specializing in innovative intranasal hydrogels, today announced that it has entered into an agreement with a globally recognized branding and trademark …

Oncocyte to Participate in 24th Annual Needham Virtual Healthcare Conference
IRVINE, Calif., April 02, 2025 (GLOBE NEWSWIRE) -- Oncocyte Corp. (Nasdaq: OCX), a leading diagnostics technology company, today announced that Chief Executive Officer Josh Riggs and Chief Financial Officer Andrea James will attend the 24th Annual Needham …

Robex Progresses Kiniero Toward First Gold in Q4 2025
Highlights: Construction at Robex’s Kiniero Gold Project, Guinea, remains on schedule and budget - first gold pour on track for Q4 CY25. Project remains LTI free (lost time injury). Grade control drilling phase 1 contract awarded; drilling has commenced. …

CorMedix Inc. to Participate in the 24th Annual Needham Virtual Healthcare Conference
BERKELEY HEIGHTS, N.J., April 02, 2025 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions, today announced that …

Infinidat Earns 5-Star Rating in the 2025 CRN® Partner Program Guide for the Fourth Consecutive Year
WALTHAM, Mass., April 02, 2025 (GLOBE NEWSWIRE) -- Infinidat, a leading provider of enterprise storage solutions, today announced that the company has been recognized by CRN®, a brand of The Channel Company, with a 5-Star Award in the 2025 CRN Partner …

Odysight.ai to participate at MRO Americas 2025 - International trade fair in the Aerospace Industry
Omer, Israel, April 02, 2025 (GLOBE NEWSWIRE) -- Odysight.ai Inc. (Nasdaq: ODYS), a pioneering developer of AI systems for Predictive Maintenance (PdM) and Condition-Based Monitoring (CBM), today announced its participation in MRO Americas 2025, which will …

Fast Track to AV1 with Beamr: High-Quality at a Fraction of the Cost
Beamr will showcase its high-performance AV1 solutions, accelerated by NVIDIA GPUs, and with simple, competitive pricing, at the 2025 NAB Show in Las Vegas HERZLIYA, Israel, April 02, 2025 (GLOBE NEWSWIRE) -- Beamr Imaging Ltd. (NASDAQ: BMR), a leader in …

Atsena Therapeutics Announces Oversubscribed $150 Million Series C Financing to Further Advance Ocular Gene Therapy Programs
Financing led by new investor Bain Capital with participation from new investor Wellington Management and all existing investors Proceeds to support advancement of ATSN-201 through potential approval and launch as well as preclinical programs to treat …

Quoin Pharmaceuticals Announces Additional Positive ‘Whole Body’ Clinical Data from Ongoing Pediatric Netherton Syndrome Study and Approval to Initiate Testing of a Second Pediatric Patient
Continued Clear Visual Evidence of Almost Completely Healed Skin After 6 weeks Treatment High Durability of Treatment Effect of QRX003 with Continuous Daily Dosing Patient Continues Not to Require Previously Necessary Medications With Patient’s Pruritus …

Sensei Biotherapeutics to Participate in the Canaccord Genuity Horizons in Oncology Virtual Conference
BOSTON, April 02, 2025 (GLOBE NEWSWIRE) -- Sensei Biotherapeutics, Inc. (Nasdaq: SNSE), a clinical stage biotechnology company focused on the discovery and development of next-generation therapeutics for cancer patients, today announced that John Celebi, …

Pyxis Oncology to Participate in the Stifel 2025 Virtual Targeted Oncology Forum
BOSTON, April 02, 2025 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (Nasdaq: PYXS), a clinical-stage company developing next-generation therapeutics for difficult-to-treat cancers, today announced that Lara S. Sullivan, M.D., President, Chief Executive Officer …

Grove AI Welcomes Former Novartis, UCB, and Google Executives to Company Advisory Board
SAN FRANCISCO, April 02, 2025 (GLOBE NEWSWIRE) -- Grove AI, pioneer in life science automation using agentic AI, today announced the formation of its inaugural Advisory Board. Comprised of prominent leaders from pharmaceutical and technology sectors, the …

Acumen Pharmaceuticals Showcases pTau217 Trial Screening Progress in Phase 2 ALTITUDE-AD Trial and Preclinical Research Methods at AD/PD 2025 and AAN Annual Meeting
NEWTON, Mass., April 02, 2025 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a clinical-stage biopharmaceutical company developing a novel therapeutic that targets toxic soluble amyloid beta oligomers (AβOs) for the treatment of Alzheimer …

Nayax Announces Acquisition of Inepro Pay
HERZLIYA, Israel, April 02, 2025 (GLOBE NEWSWIRE) -- Nayax Ltd. (Nasdaq: NYAX; TASE: NYAX), a global commerce enablement and payments platform designed to help merchants scale their business by simplifying payments and maximizing loyalty, today announced …

SANTO TOMAS PROJECT MOVES FORWARD
VANCOUVER, Canada, April 02, 2025 (GLOBE NEWSWIRE) -- Oroco Resource Corp. (TSX-V: OCO, OTC: ORRCF) (“Oroco” or the “Company”) Last week in Culiacan, Sinaloa, Craig Dalziel, Oroco's Chairman, and other members of Oroco’s Senior Management Team met with …

Generation Bio to Present at the Needham 24th Annual Virtual Healthcare Conference
CAMBRIDGE, Mass., April 02, 2025 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq:GBIO), a biotechnology company working to change what’s possible for people living with T cell-driven autoimmune diseases, announced that Geoff McDonough, M.D., president and …

من الصقور إلى المصانع: القفزة التالية لدولة الإمارات
دبي, April 02, 2025 (GLOBE NEWSWIRE) -- دبي، الإمارات العربية المتحدة، 27 مارس 2025 - تقود Saker Capital Group تحولًا جريئًا في تقاطع الصناعة والطبيعة من خلال إطلاق أول مصنع أسمنت في العالم بدون انبعاثات ثاني أكسيد الكربون في الإمارات العربية المتحدة. …